Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
167 studies found for:    Enzalutamide
Show Display Options
Rank Status Study
1 Completed Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients
Conditions: Prostate Cancer;   Pharmacokinetics of Enzalutamide
Interventions: Drug: Enzalutamide tablet;   Drug: Enzalutamide capsule
2 Active, not recruiting Enzalutamide in Patients With High-risk Prostate Cancer
Condition: Adenocarcinoma of the Prostate
Intervention: Drug: enzalutamide
3 Active, not recruiting A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Conditions: Castration-Resistant Prostate Cancer;   Prostate Cancer
Intervention: Drug: Enzalutamide
4 Not yet recruiting Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Fulvestrant with Enzalutamide
5 Active, not recruiting Enzalutamide and Niraparib in the Treatment of Metastatic Castrate-Resistant Prostate Cancer (CRPC)
Condition: Metastatic Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Niraparib
6 Completed A Study to Investigate the Effect of Severely Diminished Liver Function on the Metabolism, Safety, and Tolerability of a Single Oral Dose of Enzalutamide in Men
Conditions: Severe Hepatic Impairment;   Normal Hepatic Function
Intervention: Drug: enzalutamide
7 Recruiting Multicentre Biomarker Study in CRPC Treated With Enzalutamide
Conditions: Prostate Cancer;   Castration Resistant;   Enzalutamide
Intervention: Drug: Enzalutamide
8 Completed A Study to Compare Capsule and Tablet Forms of MDV3100 (Enzalutamide) After Administration of a Single Set Dose Under Fasted Conditions in Healthy Male Subjects
Conditions: Healthy Subjects;   Castration Resistant Prostate Cancer (CRPC);   Relative Bioavailability;   MDV3100
Intervention: Drug: MDV3100
9 Recruiting Enzalutamide for Bladder Cancer Chemoprevention
Condition: Bladder Cancer
Intervention: Drug: Enzalutamide
10 Completed A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in Men
Conditions: Drug-Drug Interaction (DDI);   Healthy Subjects;   Pharmacokinetics of Enzalutamide
Interventions: Drug: enzalutamide;   Drug: rifampin
11 Recruiting Enzalutamide + External Beam Rt For Prostate
Condition: Intermediate Risk Prostate Cancer
Interventions: Drug: Enzalutamide;   Radiation: External Beam Radiation
12 Recruiting Enzalutamide in Combination With Carboplatin and Paclitaxel in Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: Enzalutamide;   Drug: Carboplatin;   Drug: Paclitaxel
13 Recruiting A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC)
Conditions: Prostate Carcinoma Metastatic to the Bone;   Castration Resistant Prostate Cancer
Intervention: Drug: Enzalutamide
14 Active, not recruiting Analyze the Predictive Value of Gene TMPRSS2-ETS in Response to Enzalutamide in Patients With Prostate Cancer
Condition: Hormone-refractory Prostate Cancer
Intervention: Drug: Enzalutamide
15 Active, not recruiting
Has Results
A Study to Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy
Condition: Prostate Cancer
Intervention: Drug: Enzalutamide
16 Active, not recruiting A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
Condition: Metastatic Castration-resistant Prostate Cancer (mCRPC)
Intervention: Drug: Enzalutamide
17 Active, not recruiting
Has Results
Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Bicalutamide
18 Recruiting Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
Conditions: Nonmetastatic Castration-Resistant Prostate Cancer;   Prostate Cancer;   Cancer of the Prostate
Interventions: Drug: Enzalutamide;   Drug: Placebo
19 Recruiting Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy
Condition: Adenocarcinoma of the Prostate
Interventions: Drug: Enzalutamide;   Radiation: SRT
20 Recruiting Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies
Conditions: Advanced Epithelial Ovarian;   Recurrent Epithelial Ovarian;   Fallopian Tube;   Primary Peritoneal Carcinoma
Intervention: Drug: Enzalutamide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.